Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: A case report and review of literature

Satoshi Takada, Yoshinori Hoshino, Homare Ito, Yohei Masugi, Toshiaki Terauchi, Kazuhiro Endo, Masaru Kimata, Junji Furukawa, Hiroharu Shinozaki, Kenji Kobayashi, Yoshiro Ogata

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Recently, bevacizumab has become a key drug for treatment of metastatic colorectal cancer. Molecularly targeted agents such as bevacizumab can cause life-threatening adverse effects, though they are generally considered less toxic than cytotoxic drugs. Here, we review the case of a 76-year-old male rectal cancer patient with liver metastasis who suffered extensive bowel necrosis after administration of 5-fluorouracil-based chemotherapy with bevacizumab, and required a subtotal colectomy and end-ileostomy. Microscopic findings revealed extensive mucosal necrosis in the resected colon specimen and necrosis at the muscularis propria of the descending colon. Pathological findings suggested that the mucosal damage induced by chemotherapy may be exacerbated by treatment with bevacizumab, resulting in extensive necrosis.

Original languageEnglish
Article numberhyu206
Pages (from-to)286-290
Number of pages5
JournalJapanese journal of clinical oncology
Volume45
Issue number3
DOIs
Publication statusPublished - 2015 Mar 1

Keywords

  • 5-fluorouracil
  • Bevacizumab
  • Intestinal perforation
  • Metastatic colorectal cancer
  • Necrosis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: A case report and review of literature'. Together they form a unique fingerprint.

  • Cite this

    Takada, S., Hoshino, Y., Ito, H., Masugi, Y., Terauchi, T., Endo, K., Kimata, M., Furukawa, J., Shinozaki, H., Kobayashi, K., & Ogata, Y. (2015). Extensive bowel necrosis related to bevacizumab in metastatic rectal cancer patient: A case report and review of literature. Japanese journal of clinical oncology, 45(3), 286-290. [hyu206]. https://doi.org/10.1093/jjco/hyu206